Cyberknife
CyberKnife is a frameless robotic radiosurgery system used for treating benign tumors, malignant tumors and other medical conditions. The system was invented by John R. Adler, a professor of neurosurgery and radiation oncology at Stanford University.
History[edit]
The CyberKnife system is a method of delivering radiotherapy, with the intention of targeting treatment more accurately than standard radiotherapy. The idea behind the system was to combine the latest advances in robotics and image guidance technology. The first treatments were performed in 1994.
Design[edit]
The CyberKnife system is composed of a compact linear accelerator, which generates high-energy radiation, mounted on a robotic arm. The system uses image guidance software to track and continually adjust treatment for any patient or tumor movement. This continual adjustment is what allows the system to deliver a high dose of radiation with extreme accuracy.
Treatment[edit]
The CyberKnife system is used to treat conditions within the body, including tumors within the spine, lung, prostate, liver and pancreas. It can also be used to treat conditions within the head, neck and brain. The system is able to deliver beams of high dose radiation to tumors with extreme accuracy.
Advantages[edit]
Unlike traditional surgery, treatment with the CyberKnife system does not require any incisions. The system's extreme precision minimizes the damage to healthy tissues and organs. This precision also allows tumors and other conditions that may be considered inoperable or untreatable by other methods to be treated.
Disadvantages[edit]
While the CyberKnife system has many advantages, it also has some disadvantages. These include the fact that it is a relatively new technology and as such, long-term data on its effectiveness and potential side effects is not yet available. Additionally, not all tumors and conditions can be treated with the CyberKnife system.
See also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
